Kyoto, Japan

Minoru Sugita

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minoru Sugita. Retrieved from https://idiyas.com/inventor/minoru-sugita-wp9tvskd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Minoru Sugita: Innovator in Piperazine Derivatives

Introduction

Minoru Sugita is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on piperazine derivatives. His innovative approach has led to the development of valuable compounds that have potential applications in various therapeutic areas.

Latest Patents

Sugita holds 1 patent related to piperazine derivatives. The patent describes a specific formula wherein A and B can be a carbon atom or a nitrogen atom, with the exception of the case where both A and B are nitrogen atoms. This innovation showcases his expertise in chemical compounds and their potential uses in medicine.

Career Highlights

Minoru Sugita is associated with Dainippon Pharmaceutical Company, Limited, where he has been able to apply his knowledge and skills in a professional setting. His work has contributed to the advancement of pharmaceutical research and development, making a positive impact on the industry.

Collaborations

Throughout his career, Sugita has collaborated with esteemed colleagues such as Shinsaku Minami and Jun-ichi Matsumoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Minoru Sugita's contributions to the field of piperazine derivatives highlight his role as an influential inventor in the pharmaceutical industry. His work continues to inspire advancements in drug development and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…